HUNgarian COronaVirus Disease-19 Epidemiological Research

NCT ID: NCT04370067

Last Updated: 2020-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

11200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-05-01

Study Completion Date

2021-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hungarian CoronaVirus disease-19 Epidemiological Research

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The planned large-scale, cross-sectional, representative population screening can show the prevalence of COVID-19 and the degree of infection and trans-infection in Hungary after more than one month of strict restriction. In addition, it can have an impact on further actions, and we can track the impact of the decisions we make by repeating the screenings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronavirus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hungarian male or female patients aged 14 and over who live in private households
* Inactivated social security number does not infer the exclusion of the study

Exclusion Criteria

* Patients under the age of 14
* Patients living in institutional households
Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Semmelweis University

OTHER

Sponsor Role collaborator

Szeged University

OTHER

Sponsor Role collaborator

University of Pecs

OTHER

Sponsor Role collaborator

University of Debrecen

OTHER

Sponsor Role collaborator

Semmelweis University Heart and Vascular Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Béla Merkely, PhD,DSc

Role: PRINCIPAL_INVESTIGATOR

Semmelweis University Heart and Vascular Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Semmelweis University - Heart and Vascular Center

Budapest, , Hungary

Site Status RECRUITING

University of Debrecen

Debrecen, , Hungary

Site Status RECRUITING

University of Pecs

Pécs, , Hungary

Site Status RECRUITING

University of Szeged

Szeged, , Hungary

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hungary

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Béla Merkely, PhD,DSc

Role: CONTACT

+36 20 825 8000

Annamaria Kosztin, MD,PhD

Role: CONTACT

+ 36 20 666 3236

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Béla Merkely, PhD,DSc

Role: primary

+36 20 825 8000

Annamaria Kosztin, MD,PhD

Role: backup

+ 36 20 666 3236

Ervin László Berényi, MD,PhD

Role: primary

Andor Sebestyén, MD,PhD

Role: primary

Csaba Lengyel, MD,PhD

Role: primary

+36-62-545-186

References

Explore related publications, articles, or registry entries linked to this study.

Merkely B, Szabo AJ, Kosztin A, Berenyi E, Sebestyen A, Lengyel C, Merkely G, Karady J, Varkonyi I, Papp C, Miseta A, Betlehem J, Burian K, Csoka I, Vasarhelyi B, Ludwig E, Prinz G, Sinko J, Hanko B, Varga P, Fulop GA, Mag K, Voko Z; HUNgarian COronaVirus-19 Epidemiological Research (H-UNCOVER) investigators. Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary. Geroscience. 2020 Aug;42(4):1063-1074. doi: 10.1007/s11357-020-00226-9. Epub 2020 Jul 17.

Reference Type DERIVED
PMID: 32677025 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-UNCOVER

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.